10 completed, 3 withdrawn, 1 active not recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
Follow Elutia Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EluPro Antibiotic-Eluting BioEnvelope Registry EluPro Antibiotic-Eluting BioEnvelope - Cardiac Arrhythmias | Active not recruiting | Elutia Inc. | 100 | 2025-04-17 | 2026-05-28 | |
| CIED Implantation in Low BMI Patients CanGaroo - Heart Diseases, Cardiac Disease | Not applicable | Withdrawn | Elutia Inc. | 2021-06-01 | 2025-05-16 | |
| CanGaroo® Registry Study CanGaroo Envelope - Arrhythmias, Cardiac | Completed | Elutia Inc. | 500 | 2021-05-25 | 2025-05-15 | |
| Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation CIED envelope - Cardiac Disease | Completed | Elutia Inc. | 46 | 2021-02-02 | 2024-01-09 | |
| Retrospective Experience Of CIED Implantation CanGaroo Envelope, TYRX Envelope - Cardiac Disease, Heart Failure | Completed | Elutia Inc. | 597 | 2020-04-22 | 2023-07-21 | |
| A Retrospective Breast Reconstruction Study SimpliDerm HADM, AlloDerm HADM, AlloMax HADM - Breast Cancer | Completed | Elutia Inc. | 223 | 2019-11-20 | 2024-02-14 | |
| A Study Evaluating 3-Level OLIF Spine Fusion ViBone®, Demineralized Bone Matrix, Bone Morphogenetic Protein - Spondylolisthesis, Retrolisthesis | Withdrawn | Elutia Inc. | 2019-07-01 | 2023-07-20 | ||
| ViBone in Cervical and Lumbar Spine Fusion ViBone - Spondylosis, Cervical Spondylosis | Completed | Elutia Inc. | 118 | 2018-05-14 | 2025-03-04 | |
| A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope Cardiovascular Disease | Completed | Elutia Inc. | 1025 | 2015-10-01 | 2023-07-21 | |
| A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope CorMatrix CanGaroo ECM Envelope - Coronary Disease | Withdrawn | Elutia Inc. | 2015-09-01 | 2023-07-20 | ||
| A Study on the Use of CorMatrix® ECM® for Femoral Arterial Reconstruction CorMatrix ECM for Vascular Repair - Peripheral Vascular Disease | Completed | Elutia Inc. | 38 | 2015-05-01 | 2023-07-21 | |
| Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix) Coronary Disease | Completed | Elutia Inc. | 1420 | 2014-03-01 | 2023-07-21 | |
| CorMatrix ECM for Carotid Repair Following Endarterectomy Registry CorMatrix ECM for Carotid Repair - Carotid Stenosis | Completed | Elutia Inc. | 230 | 2012-04-01 | 2023-07-21 | |
| Evaluation Of New Onset Postoperative Atrial Fibrillation CorMatrix ECM for Pericardial Closure - Atrial Fibrillation New Onset | Not applicable | Completed | Elutia Inc. | 439 | 2010-12-01 | 2023-07-27 |
Heart Diseases (3) · Arrhythmias, Cardiac (2) · Coronary Disease (2) · Intervertebral Disc Degeneration (2) · Spondylolisthesis (2) · Breast Neoplasms (1) · Cardiovascular Diseases (1) · Carotid Stenosis (1) · Coronary Artery Disease (1) · Heart Failure (1) · Peripheral Vascular Diseases (1) · Spondylosis (1)
Bone Morphogenetic Proteins (1) · Grafton demineralized bone matrix gel (1)
United States (10)
Andrew Green (2) · Jerome Riebman, MD (1) · Jerry Riebman, MD, MA (1) · Marc Gerdisch, M.D. (1) · Thomas F. Deering, MD (1)